SecBot SecBot
SECBOTREPLAY Home › Report › RYTM

RYTM · A cluster of insider selling at Rhythm Pharmaceuticals, totaling $9.95M…

RHYTHM PHARMACEUTICALS, INC. · CLUSTER filed Aug 17, 2026 at 18:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Aug 17, 2026 at 18:00 ET

A cluster of insider selling at Rhythm Pharmaceuticals, totaling $9.95M in open-market sales across four senior executives, including the EVP of North America ($8.90M), the Chief Technical Officer ($608K), the Chief Scientific Officer ($182K), and the EVP of International ($257K). Several of these sales are accompanied by same-day option exercises at nominal prices, indicating a possible hedging or tax-optimization motive, but the large aggregate dollar value (0.13% of the $7.9B market cap) is notable for its C-suite breadth and coordination within a three-day window.

  • Total open-market insider selling of $9.95M over 5 trading days (Aug 10–13, 2026).
  • EVP of North America Jennifer Lee sold $8.90M (75,834 shares) at a weighted average price of ~$117.38, representing ~89% of the cluster's total value.
  • Chief Technical Officer Joseph Shulman sold $608K (5,079 shares) at $119.75.
  • Chief Scientific Officer Alastair Garfield sold $402K (7,763 shares) across multiple trades at $116–$119.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access